First Patient Treated in the United States With Quantum Surgical’s Epione Robot

Montpellier, FR (31 May 2023) – Dr. Govindarajan Narayanan, chief of interventional oncology at Miami Cancer Institute and a vascular interventional radiologist with Miami Cardiac & Vascular Institute, successfully treated the first patient in the US with a liver tumor using Quantum Surgical’s Epione robot. The procedure took place at Baptist Health South Florida in Miami, Florida, a few days after the Food and Drug Administration cleared Epione robot for treatment of all abdominal cancers. 

Quantum Surgical’s flagship product, the Epione robotic platform, is dedicated to the curative treatment of cancers. Epione allows physicians to treat inoperable tumors that are particularly difficult to reach, due to their size or their location, at an early stage, in a simple and effective way.   

More than 150 patients have already been treated with the Epione robot in Europe, and Dr. Narayanan successfully treated the first patient in the US.  

“I am honored to be the first physician to utilize Epione in the United States as this robotic-assisted equipment is going to change the way we deliver effective treatments to our patients for cancerous tumors,” said Dr. Narayanan. “Baptist Health has always been at the forefront when it comes to providing the very best care to the South Florida community and beyond. I am proud to be a part of such an incredible team.” 

“We are very proud of this first intervention with our Epione robot in the US! We are delighted to have been able to work with Dr. Narayanan and Baptist Health South Florida, renowned experts. This first intervention coincides with the FDA extension clearance to deploy our robotic solution in the United States. Dr. Narayanan is paving the way for physicians who will be able to offer more patients to benefit from innovative and less invasive treatments, and improve their lives” declares Bertin Nahum, President and co-founder of Quantum Surgical. 

Epione is a robot-assisted technology designed to plan, target, perform and confirm tumor ablation. Epione enables physicians to perform percutaneous tumor ablations, a minimally invasive treatment in which one or more needles are inserted through the skin into the tumor to destroy it.  

A demonstration video of the Epione robot is available here. 

Epione is currently available in Europe and the United States for treatment of all abdominal cancers. More than 4 million abdominal cancers occur each year worldwide1. 

About Quantum Surgical 

Quantum Surgical is a French medical robotics company, focused on developing breakthrough solutions to address complex medical issues. Its Epione^® robotic percutaneous ablation platform offers a new approach to cancer treatment by standardizing minimally invasive ablation for the curative and early treatment of cancers, allowing more patients to benefit from better-targeted and less-invasive treatments. 

Co-founded in 2017 and with a team of 100+ employees, Quantum Surgical is based in Montpellier, with an international reach. Quantum Surgical received the Prix Galien USA in 2022, the equivalent of the Nobel Prize for biopharmaceutical research.